Form 4: ANI Pharmaceuticals Executive Meredith Cook Reports Stock Transaction
SEC Form 4 Filing
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, reports disposition of shares for tax purposes following vesting of restricted stock.
Summary
- On February 28, 2025, Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, reported a transaction involving common stock.
- 1,099 shares were disposed of at a price of $61.89 per share to cover tax obligations related to the vesting of restricted stock.
- Following the transaction, Cook directly owns 80,945 shares of ANI Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing a stock transaction for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a standard tax-related stock disposal following the vesting of restricted stock, a common practice.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 02/28/2025 | Date of stock transaction (disposal of shares). |
| 03/04/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.